DSM Sinochem JV Building Second China Anti-Infective Facility  
12/19/2011 2:20:31 PM

December 19, 2011 -- DSM Sinochem Pharma announced plans to build a manufacturing facility, located in Shandong province, to produce semi-synthetic cephalosporins (SSC). The facility will use DSM Sinochem’s efficient biotech manufacturing process. The JV was formed earlier this year when Sinochem Pharma paid $291 million for a 50% stake in Royal DSM's global anti-infectives unit. More details....

Stock Symbol: (XAMS: DSM)